Clinical study of tacrolimus combined with small dose of prednisolone in treatment of IgA nephropathy

Objective To study the clinical effect of tacrolimus combined with small dose of prednisolone in treatment of IgA nephropathy. Methods 84 cases with IgA nephropathy were randomly divided into study group and the control group in accordance with the digital table method.The control group was given simple hormone treatment, while the study group was treated with tacrolimus combined with small dose of prednisolone.The clinical efficacy and safety were compared between the two groups. Results The treatment effective rate (100.00%) and complete remission rate (73.81%) of the study group were significantly higher than those in the control group (76.19%, 23.81%), and the differences were statistically significant (χ2=21.01, 11.35, P 0.05). When patients lighter (Lee's Ⅱ level), the team for complete response rate was significantly higher than the control group, and the difference was statistically significant (χ2=5.01, P 0.05). The incidence rate of adverse reactions in the study group (19.05%) was not significantly different from that of the control group (16.67%)(χ2=0.08, P>0.05). Conclusion Tacrolimus combined with small dose hormone for the treatment of IgA nephropathy has high clinical value, it can significantly reduce the level of IgA nephropathy 24h nephropathy, and adverse reactions. Key words: IgA nephropathy; Tacrolimus; Prednisolone